Previously: Congenital disorder of glycosylation, type If (CDG1F)
Erythroderma, skin thickening, scaling; neurological features.
Scaling with variable thickening and patchy desquamation; sometimes erythrodermic.
Failure to thrive, ocular anomalies, contractures microcephaly, hypotonia, delayed psychomotor development, ataxia, seizures.
Schenk B, Imbach T, Frank CG et al. MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If. J Clin Invest 2001; 108:1687-95.
Summarised from published literature for general information. This is not medical advice, and entries are still being verified. Read the full disclaimer
This feature is coming soon.
This is a reference resource for clinicians and researchers. It is not medical advice or a diagnostic tool.
The database is still being verified and entries may be incomplete. Do not rely on it without independent professional judgement.
If you are a patient, parent or carer, please speak to your doctor about any symptoms or concerns.